Key indicators: single-crystal X-ray study; T = 298 K; mean (C-C) = 0.004 Å; R factor = 0.053; wR factor = 0.136; data-to-parameter ratio = 13.9.
The title compound, C 7 H 5 Cl 2 NO 2 , crystallizes with two independent molecules in the asymmetric unit. The bond lengths and angles in both molecules are within normal ranges. In the crystal structure, weak intermolecular C-HÁ Á ÁO hydrogen bonds link the molecules into layers parallel to the [010] plane.
Related literature
For details of the biological activity of the title compound, see: Wallace et al. (2006) ; Bondinell et al. (2002) . For a related structure, see: McArdle et al. (1982) .
Experimental
Crystal data Table 1 Hydrogen-bond geometry (Å , ). et al., 2006; Bondinell et al., 2002) . In this paper, we report the crystal structure of the title compound (I).
Compound (I) crystallizes with two independent molecules in the asymmetric unit (Fig. 1) , all bond lengths and angles are normal and in a good agreement with those reported previously (McArdle et al., 1982) . The dihedral angles between the planes of the methoxycarbonyl group (C1/C2/O1/O2; C8/C9/O3/O4) and pyridine rings in the two independent molecules are 10.9 (2) and 8.1 (4)°. In the crystal structure, weak intermolecular C-H···O hydrogen bonds link the molecules into layers parallel to the b axis.
Methyl 4, 6-dichloropyridine-3-carboxylate was synthesized from Methyl 4, 6-dihydroxypyridine-3-carboxylate via chlorination with POCl 3 . The desired compound was obtained as a low melting yellow solid in 89% yield. Crystals suitable for X-ray diffraction analysis were obtained by slow evaporation of a solution in a hexane/dichloromethane mixture (1: 4 v/v) at room temperature over a period of one week.
Refinement
All H atoms were placed in calculated positions, with C-H = 0.93 or 0.96 Å, and included in the final cycles of refinement using a riding model, with U iso (H) = 1.2 times U eq (C). Primary atom site location: structure-invariant direct methods Extinction correction: none 
Special details

